Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China.
These authors contributed equally to this manuscript.
Euro Surveill. 2020 Oct;25(40). doi: 10.2807/1560-7917.ES.2020.25.40.2000250.
BackgroundThe natural history of disease in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remained obscure during the early pandemic.AimOur objective was to estimate epidemiological parameters of coronavirus disease (COVID-19) and assess the relative infectivity of the incubation period.MethodsWe estimated the distributions of four epidemiological parameters of SARS-CoV-2 transmission using a large database of COVID-19 cases and potential transmission pairs of cases, and assessed their heterogeneity by demographics, epidemic phase and geographical region. We further calculated the time of peak infectivity and quantified the proportion of secondary infections during the incubation period.ResultsThe median incubation period was 7.2 (95% confidence interval (CI): 6.9‒7.5) days. The median serial and generation intervals were similar, 4.7 (95% CI: 4.2‒5.3) and 4.6 (95% CI: 4.2‒5.1) days, respectively. Paediatric cases < 18 years had a longer incubation period than adult age groups (p = 0.007). The median incubation period increased from 4.4 days before 25 January to 11.5 days after 31 January (p < 0.001), whereas the median serial (generation) interval contracted from 5.9 (4.8) days before 25 January to 3.4 (3.7) days after. The median time from symptom onset to discharge was also shortened from 18.3 before 22 January to 14.1 days after. Peak infectivity occurred 1 day before symptom onset on average, and the incubation period accounted for 70% of transmission.ConclusionThe high infectivity during the incubation period led to short generation and serial intervals, necessitating aggressive control measures such as early case finding and quarantine of close contacts.
背景
在大流行早期,感染严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 的患者的疾病自然史仍不清楚。
目的
我们的目的是估计冠状病毒病 (COVID-19) 的流行病学参数,并评估潜伏期相对传染性。
方法
我们使用大量 COVID-19 病例和潜在病例传播对的数据库,估计了 SARS-CoV-2 传播的四个流行病学参数的分布,并根据人口统计学、流行阶段和地理位置评估了它们的异质性。我们进一步计算了发病高峰期和潜伏期内二次感染的比例。
结果
潜伏期中位数为 7.2 天(95%置信区间 (CI):6.9-7.5)。中位序列间隔和世代间隔相似,分别为 4.7 天(95%CI:4.2-5.3)和 4.6 天(95%CI:4.2-5.1)。<18 岁的儿科病例潜伏期长于成年年龄组(p=0.007)。潜伏期中位数从 1 月 25 日之前的 4.4 天增加到 1 月 31 日之后的 11.5 天(p<0.001),而序列(世代)间隔中位数从 1 月 25 日之前的 5.9(4.8)天缩短到 1 月 31 日之后的 3.4(3.7)天。从症状出现到出院的中位时间也从 1 月 22 日之前的 18.3 天缩短到 1 月 31 日之后的 14.1 天。发病高峰期平均出现在症状出现前 1 天,潜伏期占传播的 70%。
结论
潜伏期内的高传染性导致世代间隔和序列间隔缩短,需要采取早期发现病例和隔离密切接触者等积极控制措施。